Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Does ICU-acquired paresis lengthen weaning from mechanical ventilation?

  • 936 Accesses

  • 214 Citations



To determine whether ICU-acquired paresis (ICUAP) is an independent risk factor of prolonged weaning.


Second study of a prospective cohort of 95 patients who were enrolled in an incidence and risk factor study of ICUAP.


Three medical and two surgical ICUs in four hospitals.

Patients and participants

Ninety-five patients without pre-existing neuromuscular disease recovering from the acute phase of critical illness after ≥7 days of mechanical ventilation.



Measurements and results

Duration of weaning from mechanical ventilation was defined as the duration of mechanical ventilation between awakening (day 1) and successful weaning. Muscle strength was evaluated at day 7 after awakening using the Medical Research Council (MRC) score. Patients with an MRC <48 were considered to have ICUAP. Among the 95 patients (mean age 62.0±15.3 years, SAPS 2 on admission 48.7±17.4) who regained satisfactory awakening after 7 or more days of mechanical ventilation, 67 (70.5%) were hospitalized in a medical ICU and 28 (29.5%) in a surgical ICU. Median duration (25th–75th percentiles) of weaning was longer in patients with ICUAP than in those without ICUAP: 6 days (1–22 days) vs 3 days (1–7 days); p=0.01; log-rank analysis. In multivariate analysis, the two independent predictors of prolonged weaning were ICUAP [hazard ratio (HR): 2.4; 95% confidence interval (CI): 1.4–4.2] and chronic obstructive pulmonary disease (HR: 2.7; 95% CI: 1.6–4.5)


ICU-acquired paresis is an independent predictor of prolonged weaning. Prevention of ICU-acquired neuromuscular abnormalities in patients recovering from severe acute illness should result in shorter weaning duration.

This is a preview of subscription content, log in to check access.

Fig. 1


  1. 1.

    Bolton CF, Gilbert JJ, Fhahn A, Sibbald WJ (1984) Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatr 47:1223–1231

  2. 2.

    De Jonghe B, Cook D, Sharshar T, Lefaucheur J, Carlet J, Outin H (1998) Acquired neuromuscular disorders in critically ill patients: a systematic review. Intensive Care Med 24:1242–1250

  3. 3.

    De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphael JC, Outin H, Bastuji-Garin S (2002) Paresis acquired in the intensive care unit: a prospective multicenter study. J Am Med Assoc 288:2859–2867

  4. 4.

    Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481

  5. 5.

    LeGall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiologic score (SAPS II) based on a European/North American multicenter study. J Am Med Assoc 270:2957–2963

  6. 6.

    Fagon JY, Chastre J, Novara A, Medioni P, Gibert C (1993) Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med 19:137–144

  7. 7.

    Cox DR (1972) Regression models and life-tables. J R Stat Soc 34:187–220

  8. 8.

    Lemaire F (1993) Difficult weaning. Intensive Care Med 19: S69–S73

  9. 9.

    Sander HW, Saadeh PB, Chandswang N, Greenbaum D, Chokroverty S (1999) Diaphragmatic denervation in intensive care unit patients. Electromyogr Clin Neurophysiol 39:3–5

  10. 10.

    Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A, Garnacho-Montero MC, Moyano-Del-Estad MR (2001) Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 27:1288–1296

  11. 11.

    Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367

  12. 12.

    Maher J, Rutledge F, Remtulla H, Parkes A, Bernardi L, Bolton CF (1995) Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med 21:737–743

  13. 13.

    Sassoon CS, Caiozzo VJ, Manka A, Sieck GC (2002) Altered diaphragm contractile properties with controlled mechanical ventilation. J Appl Physiol 92:2585–2595

  14. 14.

    Witt NJ, Zochodne DW, Bolton CF, Grand’Maison F, Wells G, Young GB, Sibbald WJ (1991) Peripheral nerve function in sepsis and multiple organ failure. Chest 99:176–184

  15. 15.

    Multz AS, Aldrich TK, Prezant DJ, Karpel JP, Hendler JM (1990) Maximal inspiratory pressure is not a reliable test of inspiratory muscle strength in mechanically ventilated patients. Am Rev Respir Dis 142:529–532

  16. 16.

    Polkey MI, Duguet A, Luo Y, Hughes PD, Hart N, Hamnegard CH, Green M, Similowski T, Moxham J (2000) Anterior magnetic phrenic nerve stimulation: laboratory and clinical evaluation. Intensive Care Med 26:1065–1075

Download references

Author information

Correspondence to Bernard De Jonghe.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

De Jonghe, B., Bastuji-Garin, S., Sharshar, T. et al. Does ICU-acquired paresis lengthen weaning from mechanical ventilation?. Intensive Care Med 30, 1117–1121 (2004). https://doi.org/10.1007/s00134-004-2174-z

Download citation


  • Artificial respiration
  • Ventilator weaning
  • Neuromuscular disease
  • Intensive care
  • Chronic obstructive pulmonary disease